January 11, 2023 at 8:51 pm

Syros Pharmaceutics (SYRS) Jumps 18% After Announcing Clinical Updates and 2023 Strategy

Syros Pharmaceuticals (SYRS), a leader in advancing new standards of care for the frontline treatment of hematologic malignancies, jumped 18% shortly after providing clinical updates on their pipeline, and strategic priorities for 2023. Among the key critical updates were: — Expect to Complete Enrollment in SELECT-MDS-1 Phase 3 Trial in 4Q 2023; Data Expected in 3Q… [Read More]
January 11, 2023 at 9:18 am

Novocure Study Meets Primary Endpoint; Treatment Shows Improvement Over Standard Therapies

Global oncology company, Novocure (NASDAQ: NVCR) has demonstrated statistically significant and clinically meaningful improvement in overall survival of patients over standard therapies alone in its Phase 3 LUNAR study. The study is evaluating the safety and efficacy of Tumor Treating Fields (TTFields) together with standard therapies for stage 4 non-small cell lung cancer (NSCLC).  Highlights… [Read More]
January 10, 2023 at 9:19 pm

Valour Inc (DEFTF) Jumps 34%; Announces Approval of Renewed EU-Base Prospectus

Valour Inc, (DEFTF), a web 3.0 technology company, jumped 34% on the day, as the Company announced the approval of a renewed EU-base prospectus and an update on AUM & Net Sales for the month ending December 2022. The approval of their renewed EU0base prospectus will cover digital assets ETP-products by the Swedish regulator SFSA…. [Read More]
January 09, 2023 at 2:48 pm

FDA Approves Biogen’s Lecanemab

 Neuroscience pioneer, Biogen, Inc. (Nasdaq: BIIB) has received FDA approval for lecanemab for the treatment of Alzheimer’s disease (AD). The FDA’s accelerated approval is based on Phase 2 data showing a reduction in amyloid-beta plaques in early AD patients treated with lecanemab.  Highlights  Lecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against… [Read More]
January 06, 2023 at 7:10 pm

Solar Integrated Roofing Corporation (SIRC) Jumps 41%; Completes Enerev Acquisition

Solar Integrated Roofing Corporation (SIRC), a single-source solutions provider of solar power, roofing and EV charging systems, jumped up 41% for the day. The rise in value comes on the heels of announcing the completion of their Enerev acquisition. In addition to the completion, which includes the acquisition and retirement of outstanding Class C Preferred… [Read More]
January 05, 2023 at 6:11 pm

OpGen (Nasdaq:OPGN) Shares Down 18% After 1-for-20 Reverse Stock Split

Shares of OpGen (NASDAQ: OPGN) Inc. declined 18% to $2.85 Thursday after the precision medicine company’s shares began trading on a reverse-split basis. OpGen expects that the Reverse Stock Split, which was approved by its stockholders at a Special Meeting held on November 30, 2022, will increase the market price per share of common stock… [Read More]
January 04, 2023 at 9:20 pm

DMG Blockchain Solutions (DMGGF) Rises 35% in Great Day For Web 3.0

DMG Blockchain Solutions (DMGGF), a blockchain and cryptocurrency technology company, jumped up 35% for the day in a great day overall for Web 3.0. The PRISM Web 3.0 rose 11.8%, by far the biggest rise of all the PRISM Indexes. There’s no news coming from DMGGF. The latest press release is 12 days ago when… [Read More]
December 28, 2022 at 11:55 pm

PDS Biotechnology Corporation (PDSB) Rises 24% After Announces Median Overall Survival in Advanced, Refractory Cancer Patients

PDS Biotechnology Corporation (PDSB), a clinical-stage immunotherapy company, shot up 24% after announcing the median overall survival of 21 Months in advanced, refractory cancer patients with few remaining treatment options. For context, the median historical survival has been 3-4 months. In the study, all of the patients had failed with chemotherapy, and 90% of the… [Read More]